Lobular Breast Cancer - Getting the Bigger Picture on lobular breast cancer

08/11/21 • 48 min

Around 55,000 women and 370 men are diagnosed with breast cancer every year in the UK, about 15% of these are diagnosed with lobular breast cancer, but what is lobular breast cancer?
In this month's episode, Maggie spoke to Darlaine Honey about her experience of being diagnosed with lobular breast cancer, the difficulties that she faced and her drive to find better management for patients with this type of cancer. We discussed whether it might be possible to use some existing radiotracers to look at whether the disease has spread to other areas of the body and how the disease is currently managed.
Breast cancer can spread to the bones and, although there are radiotracers currently being used to find these metastases, at the School of Biomedical Engineering and Imaging Sciences at King's College London, we are looking at improving these tracers to get a more accurate picture of whether their are metastases and where they are. Dr George Keeling is working on a 'kit' which can be used to prepare one such radio tracer very easily and without the need for expensive equipment. I spoke to George about his research and about how his 'kit' is a little bit like instant noodles.
To find out more about Darlaine's story see here or here
This podcast was generously supported by the Public Engagement funding from the Centre for Medical Engineering at King's College London.

Previous Episode

Hodgkin's Lymphoma - Getting the Bigger Picture on FDG scans and radiobiology

In the first part of this episode of The Bigger Picture, Maggie talks to Vincent Kearney about his experience of being diagnosed and treated for Hodgkin's lymphoma. Vincent explains how he was diagnosed with Hodgkin's lymphoma and the treatment that he underwent. He also gives a nice explanation of what it's like having an FDG scan in the PET centre.
In the second part of the podcast, Maggie spoke to Dr Sam Terry, who works in the area of radiobiology. We find out what radiobiology is and what we might learn from Dr Terry's work to improve treatment of cancer using a different class of radioactive drugs that kill cancer cells from the inside and leaves normal tissue unharmed.
There's certainly a lot to think about from both interviews and hopefully messages that we can take from them to improve the quality and impact of our research.
Thanks to the Centre for Medical Engineering at King's College London for the Public Engagement funding for this podcast.

Next Episode

Gastrointestinal Stromal Tumour - Getting the Bigger Picture on GIST

Chris, a 42 year old father of 3, was diagnosed with a gastrointestinal stromal tumour (GIST) in 2019. Having undergone surgery and started chemotherapy, it was found that the cancer had spread to the liver.
Maggie spoke to Chris about his diagnosis, the steps that were taken to identify the cancer originally and the treatment that he subsequently had. There are some fascinating insights into how the diagnosis was made, the symptoms that led to Chris seeking medical help and how he responded to the treatment that he had. Also, some great tips to help overcome some of the stresses of living with cancer and all that goes with that.
Chris is so positive about his situation and it's an inspiration just listening to him. One of the ways that he has coped with living with his cancer is to start running again. As part of that, he has just completed the Great North Run (half marathon) and will take part in the London Marathon at the beginning of October. A combination of the running and the fundraising has helped Chris to remain so positive and it was really great to have the opportunity to chat to him about his cancer and about running.
Chris is raising money for Children with Cancer UK, you can sponsor him for the London Marathon at his Virgin Money Giving page and you can follow him on Twitter @gotthegistofit
This episode is a bit unusual in that we don't have an interview with one of our scientists about the work that they are doing with radioactive drugs for cancer but we will be putting out that interview in another episode in a couple of weeks for you to enjoy.
As ever, thanks to the Public Engagement Team at the Centre for Medical Engineering at King's College London for their support for this podcast.